Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Reuters recently reported that long-term obesity-drug sales forecasts have come down, with some 2030 estimates now around $100 billion and the prior $150 billion target pushed further out for some analysts
The key is comparing actual evidence, not just marketing promises
MACE=major adverse cardiovascular event
If youve been following medications like Ozempic , Wegovy , or Zepbound (tirzepatide) , you know they belong to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Building on these advances, liraglutide represented a significant step forward as a synthetic human GLP-1RA approved for both T2DM (Tamborlane et al., 2019) and obesity (Feinglos et al., 2005
US$ 25.06
US$ 24.72
US$ 20.73
US$ 27.83
US$ 21.10
US$ 24.70
US$ 28.03
US$ 24.10
US$ 22.09
US$ 22.47
